Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy

Clinical trial NCT00086541 · COMPLETED

Trial details

NCT number: NCT00086541
Sponsor: Bausch Health Americas, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2004-06-01
Enrollment: 515

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.